FDA Brief

Company record

Guangxi Yulin Pharmaceutical Group Co. Ltd.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Guangxi Yulin Pharmaceutical Group Co. Ltd..

Warning letters

  1. Guangxi Yulin Pharmaceutical Group Co. Ltd.

    FDA warned Guangxi Yulin Pharmaceutical Group that its OTC drugs lacked release testing and had data integrity failures.

    High risk